Why KNOS has huge potential within the months to come:
Their air filtration technology fully removes harmful allergens, bacteria, viruses (including the flu) and even gases from your breathing space. This product far outperforms the outdated 1940’s technology of a HEPA filter, and eliminates the shortcomings of any other air
Kronos owns 12 patents in total, all focused on air filtration, and the removal of harmful bacteria, allergens and viruses from the breathing space. Patents: US 7,150,780 B2 US 6,937,455 B2 US 6,919,698 B2 US 6,727,657 B2 US 7,122,070 B1 US 6,963,479 B2 US 7,053,565 B2 US 6,664,741 B1 US 2010/0047115 A1 US 2009/0022340 A1 US 2010/0065510 A1 US 2010/0065510 A1
June 18th, 2020, Kronos signs deal to acquire US based leader in electronics manufacturing industry including its 85,000 square foot manufacturing facility. Kronos announced that it has signed a “Letter of Intent” with a privately held company to acquire a manufacturing facility for its consumer electronics products operations. The Company plans to manufacture a variety of electronic products, including medical ventilators and other vitally necessary medical equipment in addition to its flagship air purification products.
Having their own manufacturing facility would not only help them to scale production to address growing sales and product line expansion, but also to develop new products and bring those to market much faster under a more efficient and controllable cost structure.
June 29th, 2020 Kronos starts taking pre-orders for air purification products.
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.